142 related articles for article (PubMed ID: 18692502)
1. Pancreatic cancer development and progression: remodeling the model.
Real FX; Cibrián-Uhalte E; Martinelli P
Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
[No Abstract] [Full Text] [Related]
2. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
3. Progression model for pancreatic cancer.
Hruban RH; Goggins M; Parsons J; Kern SE
Clin Cancer Res; 2000 Aug; 6(8):2969-72. PubMed ID: 10955772
[No Abstract] [Full Text] [Related]
4. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
5. [Biological aspects of pancreatic cancer].
Tonel E; Carbone A; Scirelli T; Bellone G; Emanuelli G
Minerva Med; 2005 Apr; 96(2):87-94. PubMed ID: 16172578
[TBL] [Abstract][Full Text] [Related]
6. Molecular changes in pancreatic cancer.
Buchholz M; Gress TM
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1487-97. PubMed ID: 19828010
[TBL] [Abstract][Full Text] [Related]
7. [Intraductal intraepithelial neoplasia and ductal pancreatic carcinoma].
Galil-Ogly GA; Paklina OV; Tsvirkun VV
Arkh Patol; 2005; 67(6):31-4. PubMed ID: 16405019
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of pancreatic cancer--new aspects and targets.
Schneider G; Hamacher R; Eser S; Friess H; Schmid RM; Saur D
Anticancer Res; 2008; 28(3A):1541-50. PubMed ID: 18630509
[TBL] [Abstract][Full Text] [Related]
9. Development of ductal adenocarcinoma during follow-up of branch-duct IPMNs.
Crippa S; Salvia R; Bassi C
Gut; 2009 Jun; 58(6):889-90. PubMed ID: 19433610
[No Abstract] [Full Text] [Related]
10. Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes.
Chifenti B; Morelli M; Zavaglia M; Coviello DA; Guerneri S; Santucci A; Paffetti A; Masetti M; Locci MT; Bertacca G; Capodanno A; Collecchi P; Campani D; Mosca F; Bevilacqua G; Cavazzana AO
Pancreas; 2009 Mar; 38(2):184-96. PubMed ID: 19002021
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.
Oji Y; Nakamori S; Fujikawa M; Nakatsuka S; Yokota A; Tatsumi N; Abeno S; Ikeba A; Takashima S; Tsujie M; Yamamoto H; Sakon M; Nezu R; Kawano K; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Oka Y; Yoshikawa K; Aozasa K; Monden M; Sugiyama H
Cancer Sci; 2004 Jul; 95(7):583-7. PubMed ID: 15245594
[TBL] [Abstract][Full Text] [Related]
12. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic ductal carcinoma: from the bench to the bedside.
Pezzilli R
JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
[No Abstract] [Full Text] [Related]
14. Location, location, location: precursors and prognoses for pancreatic cancer.
Hingorani SR
Gastroenterology; 2007 Jul; 133(1):345-50. PubMed ID: 17631154
[No Abstract] [Full Text] [Related]
15. The role of Langerhans islets in pancreatic ductal adenocarcinoma.
Pour PM
Front Biosci; 1997 Jun; 2():d271-82. PubMed ID: 9206985
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.
Rhim AD; Stanger BZ
Prog Mol Biol Transl Sci; 2010; 97():41-78. PubMed ID: 21074729
[TBL] [Abstract][Full Text] [Related]
17. Targeting cathepsins: a new glimmer of hope for pancreatic cancer therapy?
Michl P
Gut; 2012 Jun; 61(6):790-1. PubMed ID: 22287597
[No Abstract] [Full Text] [Related]
18. [Natural history of the malignant pancreatic tumor].
Furukawa M; Sasaki M; Ito M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():312-5. PubMed ID: 16457273
[No Abstract] [Full Text] [Related]
19. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
20. Pancreatic stellate cells and pancreatic carcinoma: an unholy alliance.
Löhr JM; Jesnowski R
JOP; 2009 Jul; 10(4):472-3. PubMed ID: 19581762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
